Oliguria and Proteinuria Flashcards
anuria
urine output < 50-100 mL/day
oliguria
urine output < 400-500 mL/day
polyuria
urine output < 3,000 mL/day
azotemia
elevated BUN w/o symptoms
uremia
elevated BUN w/ symptoms
sx of uremia
- n/v
- confusion
- pruritus
- metallic taste in mouth
- fatigue
- anorexia
how to differentiate b/w classifying AKI and CKD
AKI: less than 3 months w/ GFR <60 mL/min and/or markers of kidney damage present
CKD: after 3 months
describe CKD stage 1
GFR is > or equal to 90 (normal or high GFR)
describe CKD stage 2
GFR is b/w 60-89 (mild decrease)
describe CKD stage 3
GFR is b/w 45-59 (mild to moderate decrease)
describe CKD stage 4
GFR is b/w 30-44 (moderate to severe decrease)
describe CKD stage 5
GFR is b/w 15-29 (severe decrease)
vast majority of CKD cases are caused by:
diabetes or HTN
signs and sx of CKD
- edema
- HTN
- decreased urine output
- foamy urine (proteinuria)
- uremia
- pericardial friction rub
- asterixis
- uremic frost
how does creatinine affect estimated GFR
eGFR is not accurate in the setting of rapidly changing creatinine (like in AKI)
what are the 3 simple tests to identify most CKD patients
- eGFR
- urine albumin-to-creatinine ratio or protein-to-creatinine ratio
- urinalysis
what is the crockcroft-gault formula for estimating creatinine clearance
creatinine clearance = [(140-age) x lean body weight)/(serum creatinine x 72)
*x 0.85 if female
why does measuring creatinine clearance tend to overestimate GFR
b/c creatinine is freely filtered at the glomerulus but is also secreted by the tubules, making urine creatinine concentration higher than expected
purpose of using doppler renal US
evaluate for renal artery stenosis or renal vein thrombosis or resistive index
on a doppler renal US, high resistive indices (>0.7-0.8) indicate:
indicates resistance to arterial flow within the kidney
advantages of abdominal CT
better at detecting masses and kidney stones
purpose of abdominal MRI scan
can evaluate for renal artery stenosis, renal vein thrombosis, or renal masses
what are the renal US findings in a patient with CKD
- atrophic or small kidneys
- cortical thinning
- increased echogenicity
- elevated resistive indices
what are the indications for dialysis
A: severe acidosis
E: electrolyte disturbance (usually hyperkalemia)
I: ingestion (ethylene glycols, methanol, etc.)
O: volume overload
U: uremia
how to treat proteinuria in CKD patients
- low salt diet
- BP control
- ace inhibitors, ARBs, aldosterone antagonists, renin inhibitors, non-dihydropyridine CCB
what is the goal BP of CKD patients with and without proteinuria
w/ proteinuria: 140/90
w/o proteinuria: 130/80
treatment for hyperlipidemia in CKD patients
statin therapy
treatment for anemia in CKD patients
- oral or IV iron
- erythropoietin stimulating agents (ESA)
treatment for metabolic acidosis in CKD patients
bicarbonate supplementation if HCO3- is <22
treatment for hyperkalemia in CKD patients
- renal failure diet (low salt, low K+, low phosphorus)
- diuretics
- sodium polystyrene sulfonate (kayexelate) or patiromer (veltassa)
treatment for CKD-BMD (previous renal osteodystrophy) in CKD patients
- renal failure diet (low salt, low K+, low phosphorus)
- phosphorus binder (lowers phos absorption in gut)
- vitamin D supplementation
- calcimimetics (lowers PTH)